Pregabalin and Fulvestrant - a comparison of German and English liability regimes for Swiss-type claims in light of current case law1

By Stief M, Zorr U. The most recent decision of the Düsseldorf Appeal Court (OLG Düsseldorf) in the legal dispute concerning the active substance Fulvestrant (GRUR 2019, 279) is a contribution to concretisation of the new liability criteria which the court clearly formulated for the first time in the “Östrogenblocker” decision of 5 May 2017 …read more

Source:: Journal of Intellectual Property Law & Practice